Zentalis Pharmaceuticals Inc (ZNTL)

04:16 AM

Zentalis to present azenosertib data at cancer therapeutics conference - Investing.com India

04:16 AM

04:15 AM

Zentalis Pharmaceuticals Announces Acceptance of Azenosertib Abstracts for Presentation at AACR-NCI-EORTC Conference - Quiver Quantitative

04:15 AM

10:32 AM

Will Zentalis Pharmaceuticals Inc. stock keep outperforming rivalsJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com

10:32 AM

10:24 AM

How Zentalis Pharmaceuticals Inc. stock benefits from strong dollarGap Up & Stepwise Entry and Exit Trade Signals - newser.com

10:24 AM

09:44 AM

How currency fluctuations impact Zentalis Pharmaceuticals Inc. stockWall Street Watch & Risk Managed Investment Signals - newser.com

09:44 AM

Oct 12, 2025

Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress - ADVFN Ltd

Oct 12, 2025

Oct 12, 2025

Can Zentalis Pharmaceuticals Inc. hit a new high this monthTrade Risk Summary & Weekly High Potential Stock Alerts - newser.com

Oct 12, 2025

Oct 11, 2025

Zentalis Pharmaceuticals, Inc. $ZNTL Shares Sold by Wealth Enhancement Advisory Services LLC - Defense World

Oct 11, 2025

Oct 10, 2025

What institutional flow reveals about Zentalis Pharmaceuticals Inc.Market Sentiment Review & Community Trade Idea Sharing - newser.com

Oct 10, 2025

Oct 10, 2025

Weiss Ratings Reaffirms Sell (E+) Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL) - Defense World

Oct 10, 2025

Oct 09, 2025

What earnings revisions data tells us about Zentalis Pharmaceuticals Inc.Weekly Trade Report & Entry Point Confirmation Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Full technical analysis of Zentalis Pharmaceuticals Inc. stockJuly 2025 Review & AI Optimized Trade Strategies - newser.com

Oct 09, 2025

Oct 09, 2025

Using data filters to optimize entry into Zentalis Pharmaceuticals Inc.Watch List & Verified Technical Trade Signals - newser.com

Oct 09, 2025

Oct 08, 2025

Zentalis Pharmaceuticals' (ZNTL) "Sell (E+)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 08, 2025

Oct 06, 2025

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock - Yahoo Finance

Oct 06, 2025

Oct 06, 2025

Key metrics from Zentalis Pharmaceuticals Inc.’s quarterly dataQuarterly Market Summary & Stepwise Swing Trade Plans - newser.com

Oct 06, 2025

Oct 05, 2025

Short interest data insights for Zentalis Pharmaceuticals Inc.2025 Fundamental Recap & Verified Short-Term Plans - newser.com

Oct 05, 2025

Oct 05, 2025

Pattern recognition hints at Zentalis Pharmaceuticals Inc. upsideJuly 2025 Review & Target Return Focused Picks - newser.com

Oct 05, 2025

Oct 05, 2025

How to build a dashboard for Zentalis Pharmaceuticals Inc. stockMarket Activity Report & Smart Swing Trading Techniques - newser.com

Oct 05, 2025

Oct 03, 2025

Positive week for Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) institutional investors who lost 48% over the past year - simplywall.st

Oct 03, 2025

Oct 02, 2025

What analysts say about Zentalis Pharmaceuticals Inc stockDebt-to-Equity Ratio Analysis & Ride the Trends That Billionaires Follow - earlytimes.in

Oct 02, 2025

Oct 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 01, 2025

Oct 01, 2025

400,000 Stock Options at $1.54: Zentalis Pharmaceuticals Welcomes New Chief Legal Officer with Major Grant - Stock Titan

Oct 01, 2025

Sep 25, 2025

Zentalis Pharmaceuticals, Inc. $ZNTL Shares Sold by Goldman Sachs Group Inc. - Defense World

Sep 25, 2025

Sep 25, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Sep 25, 2025